sepsis. Urinary tract infection
Conditions
Interventions
Intervention 1: Intervention group: Patients who take interferon gamma-1b (Gammarec) daily with standard treatment for 5 days. Intervention 2: Control group: Patients who take only standard treatment.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age 18 to 75 years Patients who have legally accepted using the medicine Patients that hospitalized in ICU or wards under special supervision with diagnosis of septic shock or severe sepsis, sepsis and critical illness
Exclusion criteria
Exclusion criteria: during pregnancy and breastfeeding Simultaneous use with Deferiprone Hypersensitivity to interferon gamma 1-b (Gammarec) medicine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of the gamma interferon medicine (Gammarec) using on sepsis patients. Timepoint: from the beginning of taking the medicine for 5 days. Method of measurement: Based on physicians and nurses reports and clinical and laboratory observations. | — |
Secondary
| Measure | Time frame |
|---|---|
| The frequency of death due to the sepsis;. Timepoint: from the beginning of taking the medicine for 5 days. Method of measurement: based on patient clinical report.;Number of people discharged from ICU after treatment by Gammarec. Timepoint: from the beginning of taking the medicine for 5 days. Method of measurement: Based on physicians and nurses reports and clinical and laboratory observations. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Ali Dehghan Manshadi
Tehran University of Medical Sciences
Outcome results
None listed